Position in IBRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$30,824,724
+$20,714,424 QoQ
Shares Held
4,018,869
-21.3% QoQ
Ownership
0.384%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 85.81118220076345.ToString("F0")%
Shared 0.ToString("F0")%
None 14.188817799236553.ToString("F0")%
Common Shares in IBRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,438,935,225 across 518 Biotechnology names. IBRX ranks #76 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in IBRX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $30,824,724 | 4,018,869 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $10,110,300 | 5,106,214 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $8,298,979 | 3,373,570 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $7,846,785 | 2,972,269 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $5,704,351 | 1,895,134 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $10,254,879 | 4,005,814 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $8,358,434 | 2,246,892 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $3,592,290 | 568,401 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $3,354,104 | 624,601 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $3,010,581 | 599,718 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $672,448 | 397,901 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $974,795 | 350,647 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,044,249 | 573,766 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,758,877 | 544,158 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $3,189,807 | 641,813 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,640,548 | 978,643 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $6,022,439 | 1,073,519 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $2,631,567 | 432,824 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $4,847,829 | 497,724 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $6,972,779 | 488,290 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $7,907,200 | 333,075 | Shares | Defined | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||